Hints and tips:
Related Special Reports
...Reckitt previously sought a sale of the business in 2022. Speaking to the Financial Times following the Illinois verdict, Licht did not confirm or deny that the company was exploring a sale again....
...“What is most important is that it kills antibiotic-resistant strains in animals,” said Yury Polikanov, co-author of the research and an associate professor of biological sciences at the University of Illinois...
...The company has genetically validated two other drug targets....
...The EU top court has ruled that the name of the late Colombian drug kingpin Pablo Escobar will not be registered as a trademark in the European Union....
...The jury in an Illinois state court came to the conclusion that one of its formulas for premature babies, Enfamil Premature 24, which is manufactured by Reckitt’s US infant formula business Mead Johnson,...
...One problem has been the lack of funding for discovery of new drugs as bacterial resistance to older ones has swelled....
...Tirzepatide is part of a new class of weight-loss drugs, known as GLP-1s, which includes Novo Nordisk’s Wegovy and Ozempic drugs, that are projected to expand to a $100bn market by the end of the decade,...
...Drugs companies issued 1,643 warnings of impending shortages in 2023, compared to 648 in 2020, the research found....
...The company’s immunotherapy drug Imfinzi helped patients with so-called limited stage small cell lung cancer survive for longer....
...Finding an effective treatment for Alzheimer’s has proved fiendishly difficult for drug companies, and previous regulatory decisions in the field have stirred controversy....
...A top EU court has ruled that the name of the dead Colombian drug kingpin Pablo Escobar cannot be registered as a trademark in the EU....
...Soaring sales of the products have pushed the companies’ valuations to record highs....
...Just 12 Nasdaq 100 companies currently issue convertible bonds, and none of the top 25 by market capitalisation, according to data from Illinois-based Calamos Investments, a $35.5bn house which manages $11bn...
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...Novo Nordisk has agreed to acquire three manufacturing sites for $11bn, as the Danish drugmaker races to expand production of the weight loss drugs whose runaway success has sent the company’s valuation...
...Bobby Gaspar, co-founder and chief executive of Orchard, said Lenmeldy was “a paradigm-shifting medicine”, adding that the company was “committed to enabling broad, expedient and sustainable access to this...
...Some drugs might be effective in the early, but not the late stages of the disease. As with cancer, MASH may require combinations of drugs tailored to different patient’s needs....
...Scotland approved the drug in December. It has a list price of £1,455 per vial, although it is available to the NHS at an undisclosed discount....
...Instead, drugs companies will be on the hook for an uncapped 20 per cent share of catastrophic costs....
...Enhertu is one of a new generation of cancer drugs known as antibody drug conjugates that are more targeted than traditional chemotherapy drugs....
...Sales of its diabetes and obesity drugs have sent Novo Nordisk’s market capitalisation soaring but the company has also set a goal of diversifying, including into the treatment of cardiovascular diseases...
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...But according to Holst, who has worked as a consultant for the company, it has struggled to develop small-molecule GLP-1 drugs, which are much easier and cheaper for manufacturers to produce at scale....
...Sales of cancer drugs helped AstraZeneca to beat City expectations in 2023, as the FTSE 100 company forecast continued double-digit sales growth in 2024....
...The company plans to “move forward as quickly as possible” with further trials in MASH for the drug....
International Edition